Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

The genetic shortcut to antibody drugs

Credit: Sam Falconer

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 564, S16-S17 (2018)

doi: https://doi.org/10.1038/d41586-018-07645-x

This article is part of Nature Outlook: Gene therapy, an editorially independent supplement produced with the financial support of third parties. About this content.

References

  1. Andrews, C. D. et al. Mol. Ther. Methods Clin. Dev. 7, 74–82 (2017).

    Article  PubMed  Google Scholar 

  2. Liu, W. et al. J. Neurosci. 36, 12425–12435 (2016).

    Article  PubMed  Google Scholar 

  3. Pardi, N. et al. Nature Commun. 8, 14630 (2017).

    Article  PubMed  Google Scholar 

  4. Thran, M. et al. EMBO Mol. Med. 9, 1434–1447 (2017).

    Article  PubMed  Google Scholar 

  5. Stadler, C. R. et al. Nature Med. 23, 815–817 (2017).

    Article  PubMed  Google Scholar 

Download references

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links